ATE547105T1 - Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems - Google Patents

Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems

Info

Publication number: ATE547105T1
Authority: AT; Austria
Prior art keywords: glucosamine; derivatives; treatment; transglutaminase; nervous system
Prior art date: 2005-08-03

Application number

AT06769018T

Other languages

English (en)

Inventor

Soo Youl Kim

Original Assignee

Nat Cancer Ct

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-03

Filing date

2006-06-23

Publication date

2012-03-15

2006-06-23 Application filed by Nat Cancer Ct filed Critical Nat Cancer Ct

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE547105T1 publication Critical patent/ATE547105T1/de

Links

MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 title abstract 4
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 title abstract 4
229960002442 glucosamine Drugs 0.000 title abstract 4
108060008539 Transglutaminase Proteins 0.000 title abstract 3
102000003601 transglutaminase Human genes 0.000 title abstract 3
230000004064 dysfunction Effects 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
210000000653 nervous system Anatomy 0.000 title 1
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
230000002401 inhibitory effect Effects 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
229940098113 Transglutaminase inhibitor Drugs 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000001747 exhibiting effect Effects 0.000 abstract 1
230000002018 overexpression Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT06769018T 2005-08-03 2006-06-23 Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems ATE547105T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR20050070862		2005-08-03
PCT/KR2006/002438 WO2007026996A1 (en)	2005-08-03	2006-06-23	Glucosamine and derivatives thereof useful as tg inhibitors

Publications (1)

Publication Number	Publication Date
ATE547105T1 true ATE547105T1 (de)	2012-03-15

Family

ID=37809057

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06769018T ATE547105T1 (de)	2005-08-03	2006-06-23	Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems

Country Status (6)

Country	Link
US (1)	US20090029943A1 (de)
EP (1)	EP1909804B1 (de)
JP (1)	JP2009503061A (de)
CN (1)	CN101155591B (de)
AT (1)	ATE547105T1 (de)
WO (1)	WO2007026996A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100878585B1 (ko)	2006-06-16	2009-01-15	국립암센터	글루코사민, 글루코사민 유도체 또는 이들의 염을 포함하는항암감작제
KR20080108797A (ko) *	2007-06-11	2008-12-16	국립암센터	Ｅｇｃｇ를 포함하는 트란스글루타미나제 억제제 및 그의제조방법
KR101145930B1 (ko) *	2007-06-11	2012-05-15	국립암센터	클로로겐산을 포함하는 트란스글루타미나제 억제제 및 그의제조방법
US8694505B2 (en) *	2009-09-04	2014-04-08	Microsoft Corporation	Table of contents for search query refinement
KR101762134B1 (ko)	2014-09-16	2017-07-27	건국대학교 산학협력단	이분자 형광 상보 시스템을 이용한 알파-시뉴클린 응집체의 세포간 전이 측정방법 및 이를 이용한 퇴행성 신경질환의 예방 또는 치료용 물질의 스크리닝 방법
IT201800003912A1 (it) *	2018-03-26	2019-09-26	Innovet Italia Srl	N-palmitoil-d-glucosamina in forma micronizzata

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU213677B (en) *	1993-11-09	1997-12-29	Immunal Kft	Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
EP0923382B1 (de) *	1996-08-09	2002-05-29	Mannatech, Inc.	Zusammensetzungen auf pflanzliicher kohlenhydratbasis als nahrungsergänzungsstoffe
EP1201136A1 (de) *	2000-10-31	2002-05-02	Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO	Transglutaminasehemmer mit Nahrungsmittelqualitität und Verwendungen davon
CN1131036C (zh) *	2001-02-28	2003-12-17	中国人民解放军第三军医大学	N－乙酰－d－氨基葡萄糖在制备抑制放化疗副反应药物中的应用
KR100465229B1 (ko) *	2001-04-09	2005-01-13	주식회사 안지오랩	2-아미노-2-데옥시-ｄ-글루코피라노오즈 또는 그의약학적으로 허용가능한 염을 유효성분으로 하는 혈관신생억제용 약학적 조성물
DE10126396A1 (de) *	2001-05-31	2002-12-05	Beiersdorf Ag	Verwendung von Glucosamin zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
US20040105889A1 (en) *	2002-12-03	2004-06-03	Elan Pharma International Limited	Low viscosity liquid dosage forms
US20050239749A1 (en) *	2002-07-25	2005-10-27	Lion Corporation	External preparation
JP4422392B2 (ja) *	2002-08-20	2010-02-24	焼津水産化学工業株式会社	記憶学習能改善剤
KR20040065979A (ko) *	2003-01-16	2004-07-23	김정식	황산 글루코사민과 비타민 비12를 활성성분으로 함유하는퇴행성 관절염 치료용 조성물
WO2004069175A2 (en) *	2003-02-02	2004-08-19	Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES
US7511026B2 (en) *	2003-03-25	2009-03-31	Seikagaku Corporation	Therapeutic agent for nerve damage
US20070207198A1 (en) *	2003-09-17	2007-09-06	Beijing Sino-Hong Kong Dafu Science & Technology Of Biowave Co., Ltd.	Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
KR100878585B1 (ko) *	2006-06-16	2009-01-15	국립암센터	글루코사민, 글루코사민 유도체 또는 이들의 염을 포함하는항암감작제

2006
- 2006-06-23 US US11/918,339 patent/US20090029943A1/en not_active Abandoned
- 2006-06-23 CN CN2006800115371A patent/CN101155591B/zh not_active Expired - Fee Related
- 2006-06-23 JP JP2008524879A patent/JP2009503061A/ja active Pending
- 2006-06-23 AT AT06769018T patent/ATE547105T1/de active
- 2006-06-23 WO PCT/KR2006/002438 patent/WO2007026996A1/en not_active Ceased
- 2006-06-23 EP EP06769018A patent/EP1909804B1/de not_active Not-in-force

Also Published As

Publication number	Publication date
CN101155591B (zh)	2012-01-18
JP2009503061A (ja)	2009-01-29
EP1909804B1 (de)	2012-02-29
US20090029943A1 (en)	2009-01-29
CN101155591A (zh)	2008-04-02
EP1909804A4 (de)	2010-05-26
WO2007026996A1 (en)	2007-03-08
EP1909804A1 (de)	2008-04-16

Publication	Publication Date	Title
MX2023007192A (es)	2023-07-03	Inhibidores de prmt5.
MY148851A (en)	2013-06-14	Dihydropyridine derivatives as useful as protein kinase inhibitors
NO20092569L (no)	2009-07-06	Inhibitorer av Akt-aktivitet
MA32393B1 (fr)	2011-06-01	Composés et compositions servant d'inhibiteurs de kinases
MY139689A (en)	2009-10-30	Imidazotriazines as protein kinase inhibitors
TW200720268A (en)	2007-06-01	1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
MX2009004791A (es)	2009-08-19	Derivados de anilinopiperazina t metodos de uso de los mismos.
ATE520668T1 (de)	2011-09-15	Sigmarezeptor-inhibitoren
ATE463490T1 (de)	2010-04-15	Histondeacetylase-hemmer
MX2009004785A (es)	2009-06-05	Amidas 2-aminotiazol-4-carboxilicas como inhibidores de proteina quinasa.
NO20010743L (no)	2001-04-05	Antivirale indoloksoacetyl-piperazin-derivater
NO20090723L (no)	2009-02-13	Kondenserte heterosykliske derivater og fremgangsmater for anvendelse
EA200970447A1 (ru)	2009-10-30	Соединения и композиции в качестве ингибиторов протеинкиназы
BR112013010310A2 (pt)	2016-11-29	inibidores de acetil-coa carboxilase de lactama n1/n2
TW200736229A (en)	2007-10-01	Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
SV2009003212A (es)	2010-08-10	Inhibidores de metaloproteasa derivados de heterociclicos ref. prd2727svpct
MX2010004876A (es)	2010-07-28	Derivados de diamido tiazol como inhibidores de la proteina cinasa.
NO20080417L (no)	2008-03-18	Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET
ATE502935T1 (de)	2011-04-15	C-met-proteinkinasehemmer
PL1919466T3 (pl)	2012-05-31	Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
NO20073610L (no)	2007-09-12	Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
EP1909804A4 (de)	2010-05-26	Glucosamin und derivate davon als tg-inhibitoren
WO2007081808A3 (en)	2008-04-03	Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity
ATE469168T1 (de)	2010-06-15	Peptide zur transglutaminase-hemmung
TW200603791A (en)	2006-02-01	Compounds and compositions as cathepsin S inhibitors